MedPath

CONNECT: Telecare health coaching management of low back pain in primary care to improve disability

Not Applicable
Conditions
sub-acute
Chronic low back pain
Musculoskeletal - Other muscular and skeletal disorders
Registration Number
ACTRN12618001628235
Lead Sponsor
niversity of Sydney
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot yet recruiting
Sex
All
Target Recruitment
300
Inclusion Criteria

Participants will be included if they:
•Are older than 18 years of age
•Have a diagnosis of NSLBP
•Present with symptoms for at least 6 weeks duration
•Consent for details to be passed to trial co-ordinator
•Basic smart phone/tablet device or computer literacy

Exclusion Criteria

Participants will be excluded if they have:
•Known or suspected serious spinal pathology (fracture, metastatic, inflammatory or infective diseases, widespread neurological disorder, radiculopathy).
•A diagnosis of specific low back pain, i.e. sciatica, spinal stenosis.
•Back surgery within the previous 2 years.
•Co-morbid health conditions that would prevent active participation in the physical activity programs (e.g. unstable angina, uncontrolled hypertension).
•Inadequate English to participate in behavioural interviewing or complete outcome measures.
•Any disorder that may reduce capacity to understand and follow simple instructions

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Patient Specific Functional Scale<br>This is a condition-specific measure used to quantify activity limitation and function in patients with musculoskeletal pain. The participant will be asked to identify three important activities that they are unable to do or are having difficulty with as a result of their LBP. They will rate each activity using a numerical rating scale of 0-10 (0 meaning unable to perform activity and 10 meaning able to perform activity to the same level as before the injury or/problem). This will take approximately 2 minutes to complete.<br>This is a validated measure that has not been specifically designed for the study.[The measure will be taken at baseline, 3 months, 6 months (primary end point) and 12 months after randomisation]
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath